Synthesis of (E)- and (Z)-fluoro-olefin analogues of potent dipeptidyl peptidase IV inhibitors

被引:34
|
作者
Van der Veken, P [1 ]
Kertèsz, I [1 ]
Senten, K [1 ]
Haemers, A [1 ]
Augustyns, K [1 ]
机构
[1] Univ Instelling Antwerp, Dept Med Chem, B-2610 Antwerp, Belgium
关键词
D O I
10.1016/S0040-4039(03)01542-9
中图分类号
O62 [有机化学];
学科分类号
070303 ; 081704 ;
摘要
(E)- and (Z)-fluoro-olefin analogues of potent dipeptidyl peptidase IV inhibitors were synthesized. A WadsworthHorner-Eminons reaction, followed by amide formation and reduction of the amide were used for the construction of the alpha-fluoro-alpha,beta-unsaturated amine functionality. (C) 2003 Elsevier Ltd. All rights reserved.
引用
收藏
页码:6231 / 6234
页数:4
相关论文
共 50 条
  • [31] Design and synthesis of pyrrolidine amino amides as dipeptidyl peptidase IV inhibitors
    Tang Peng Cho
    Yang Fang Long
    Zhang Lei
    Shen Guang Yuan
    Luo Jing Jing
    Li Xin
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 237
  • [32] Design and synthesis of long-acting inhibitors of dipeptidyl peptidase IV
    Kondo, Takashi
    Sugimoto, Isamu
    Nekado, Takahiro
    Ochi, Kenya
    Ohtani, Tazumi
    Tajima, Yohei
    Yamamoto, Susumu
    Kawabata, Kazuhito
    Nakai, Hisao
    Toda, Masaaki
    BIOORGANIC & MEDICINAL CHEMISTRY, 2007, 15 (07) : 2715 - 2735
  • [33] Suppression of arthritis by the inhibitors of dipeptidyl peptidase IV
    Tanaka, S
    Murakami, T
    Horikawa, H
    Sugiura, M
    Kawashima, K
    Sugita, T
    INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1997, 19 (01): : 15 - 24
  • [34] Fluoropyrrolidine amides as dipeptidyl peptidase IV inhibitors
    Caldwell, CG
    Chen, P
    He, JF
    Parmee, ER
    Leiting, B
    Marsilio, F
    Patel, RA
    Wu, JK
    Eiermann, GJ
    Petrov, A
    He, HB
    Lyons, KA
    Thornberry, NA
    Weber, AE
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (05) : 1265 - 1268
  • [35] Recent patents of dipeptidyl peptidase IV inhibitors
    Mendieta, Laura
    Tarrago, Teresa
    Giralt, Ernest
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2011, 21 (11) : 1693 - 1741
  • [36] Dipeptidyl peptidase iv inhibitors and diabetes therapy
    McIntosh, Christopher H. S.
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2008, 13 : 1753 - 1773
  • [37] Synthesis and evaluation of pyrazolidine derivatives as dipeptidyl peptidase IV (DP-IV) inhibitors
    Ahn, JH
    Kim, JA
    Kim, HM
    Kwon, HM
    Huh, SC
    Rhee, SD
    Kim, KR
    Yang, SD
    Park, SD
    Lee, JM
    Kim, SS
    Cheon, HG
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (05) : 1337 - 1340
  • [38] The development of a structurally distinct series of BACE1 inhibitors via the ( Z )-fluoro-olefin amide bioisosteric replacement
    Frohn, Michael
    Liu, Longbin
    Siegmund, Aaron C.
    Qian, Wenyuan
    Amegadzie, Albert
    Chen, Ning
    Tan, Helming
    Hickman, Dean
    Wood, Stephen
    Wen, Paul H.
    Bartberger, Michael D.
    Whittington, Douglas A.
    Allen, Jennifer R.
    Bourbeau, Matthew P.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2020, 30 (14)
  • [39] Concise and efficient synthesis of highly potent and selective dipeptidyl peptidase II inhibitors
    Rasheed, M. Abdul
    Namala, Rambabu
    Manne, Narendra
    Vanjivaka, Sreelatha
    Dhamjewar, Ravi
    Balasubramanian, Gopalan
    SYNTHETIC COMMUNICATIONS, 2008, 38 (02) : 162 - 169
  • [40] CoMFA and CoMSIA of diverse pyrrolidine analogues as dipeptidyl peptidase IV inhibitors: active site requirements
    Murugesan, Vanangamudi
    Sethi, Nidhi
    Prabhakar, Yenamandra S.
    Katti, Seturam B.
    MOLECULAR DIVERSITY, 2011, 15 (02) : 457 - 466